John Perrett

Phase II study of a neutrophil elastase inhibitor (AZD9668) in patients with bronchiectasis

Robert A. Stockley, Anthony De Soyza, Kulasiri A. Gunawardena et al. · Respiratory Medicine · 2013 · 203 citations

Veterinary Medicine, Immunology, Pharmacotherapy +14

A Randomised, Placebo-Controlled, Dose-Finding Study Of AZD9668, An Oral Inhibitor of Neutrophil Elastase, in Patients with Chronic Obstructive Pulmonary Disease Treated with Tiotropium

Claus Vogelmeier, Teresita O. Aquino, Christopher D. O’Brien et al. · COPD Journal of Chronic Obstructive Pulmonary Disease · 2012 · 93 citations

Medicine, Clinical Sciences, Pharmacotherapy +16

Efficacy, safety and effect on biomarkers of AZD9668 in cystic fibrosis

J.S. Elborn, John Perrett, Kristina Forsman‐Semb et al. · European Respiratory Journal · 2012 · 82 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +16

Pharmacokinetic and pharmacodynamic assessment of a five‐probe metabolic cocktail for CYPs 1A2, 3A4, 2C9, 2D6 and 2E1

Graham Blakey, J.A. Lockton, John Perrett et al. · British Journal of Clinical Pharmacology · 2003 · 65 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

Pharmacokinetics and safety of AZD9668, an oral neutrophil elastase inhibitor, in healthy volunteers and patients with COPD

Kulasiri A. Gunawardena, Helena Gullstrand, John Perrett · International Journal of Clinical Pharmacology and Therapeutics · 2013 · 26 citations

Medicine, Pharmacokinetics, Pharmacology +17